NRO — Neurones SA Balance Sheet

0.000.00%

Last trade - 00:00

TechnologyBalancedMid CapHigh Flyer

Annual balance sheet for Neurones SA, fiscal year end - December 31st, EUR millions except per share, conversion factor applied.

	2019 December 31st	2020 December 31st	2021 December 31st	R2022 December 31st	2023 December 31st
Period Length:	—	—	—	—	—
Source:	ARS	ARS	ARS	ARS	ARS
Standards:	IFRS	IFRS	IFRS	IFRS	IFRS
Status:	Final	Final	Final	Final	Final
Cash
Cash and Equivalents
Short Term Investments
Cash and Short Term Investments	218	266	265	272	297
Net Total Accounts Receivable
Net Total Receivables	186	176	190	225	236
Total Inventory
Prepaid Expenses
Total Current Assets	413	449	464	507	546
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment	47.1	46.6	46.1	48.8	58.7
Net Goodwill
Net Intangible Assets
Long Term Investments
Other Long Term Assets
Total Assets	510	550	568	616	674
Accounts Payable
Accrued Expenses
Notes Payable / Short Term Debt
Current Portion of Long Term Debt / Capital Leases
Total Other Current Liabilities
Total Current Liabilities	156	161	185	207	229
Long Term Debt
Capital Lease Obligations
Total Long Term Debt
Total Debt
Deferred Income Tax
Minority Interest
Total Other Liabilities
Total Liabilities	213	227	256	286	320
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Total Equity	297	323	312	331	354
Total Liabilities & Shareholders' Equity	510	550	568	616	674
Total Common Shares Outstanding